{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:52:31Z","timestamp":1790751151535,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013991","name":"Texas A&M University Health Sciences Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013991","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.niox.2024.04.009","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T15:36:43Z","timestamp":1713454603000},"page":"13-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Nanoparticle-mediated delivery of tetrahydrobiopterin restores endothelial function in diabetic rats"],"prefix":"10.1016","volume":"148","author":[{"given":"Katherine A.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristine L.","family":"Heaps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Labhasetwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1314-5044","authenticated-orcid":false,"given":"Cynthia J.","family":"Meininger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2024.04.009_bib33","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1096\/fj.04-1702fje","article-title":"GTP cyclohydrolase I gene transfer reverses tetrahydrobiopterin deficiency and increases nitric oxide synthesis in endothelial cells and isolated vessels from diabetic rats","volume":"18","author":"Meininger","year":"2004","journal-title":"Faseb. J."},{"key":"10.1016\/j.niox.2024.04.009_bib7","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1161\/CIRCULATIONAHA.111.038919","article-title":"Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease","volume":"125","author":"Cunnington","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2024.04.009_bib49","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1042\/bj3620733","article-title":"The ratio between tetrahydrobiopterin and oxidized tetrahydropterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study","volume":"362","author":"Vasquez-Vivar","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.niox.2024.04.009_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/bj3230159","article-title":"Characterization of bovine endothelial nitric oxide synthase as a homodimer with down-regulated uncoupled NADPH oxidase activity: tetrahydrobiopterin binding kinetics and role of haem in dimerization","volume":"323","author":"List","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.niox.2024.04.009_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejps.2012.05.010","article-title":"Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNPs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNPs and NLCs?","volume":"47","author":"Das","year":"2012","journal-title":"Eur J Pharm Sciences"},{"key":"10.1016\/j.niox.2024.04.009_bib15","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1517\/17425247.2011.604311","article-title":"Solid lipid nanoparticles: an oral bioavailability enhancer vehicle","volume":"8","author":"Harde","year":"2011","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.niox.2024.04.009_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejps.2010.10.002","article-title":"Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting","volume":"42","author":"Aji","year":"2011","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.niox.2024.04.009_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.colsurfb.2012.04.027","article-title":"Formulation and evaluation of nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system","volume":"97","author":"Chalikwar","year":"2012","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.niox.2024.04.009_bib39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nano.2008.08.003","article-title":"Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery","volume":"5","author":"Paliwal","year":"2009","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.niox.2024.04.009_bib35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0076-6879(02)52026-7","article-title":"Regulation of endothelial cell proliferation by nitric oxide","volume":"352","author":"Meininger","year":"2002","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.niox.2024.04.009_bib40","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/jps.20094","article-title":"Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA\/PLA nanoparticles","volume":"93","author":"Panyam","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.niox.2024.04.009_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1074\/jbc.M004392200","article-title":"L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin","volume":"276","author":"Heller","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2024.04.009_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2023.10.028","article-title":"Catalytic antioxidant nanoparticles mitigate secondary injury progression and promote functional recovery in spinal cord injury model","volume":"364","author":"Jaffer","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.niox.2024.04.009_bib17","doi-asserted-by":"crossref","first-page":"H1128","DOI":"10.1152\/ajpheart.00973.2005","article-title":"Exercise training increases basal tone in arterioles distal to chronic coronary occlusion","volume":"290","author":"Heaps","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.niox.2024.04.009_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0003-2697(80)90336-X","article-title":"Analysis of reduced forms of biopterin in biological tissues and fluids","volume":"102","author":"Fukushima","year":"1980","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.niox.2024.04.009_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1042\/bj3490353","article-title":"Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency","volume":"349","author":"Meininger","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.niox.2024.04.009_bib10","first-page":"51","article-title":"Characterization of nanoparticle uptake by endothelial cells","volume":"233","author":"Davda","year":"2002","journal-title":"Ind. J. Pharm."},{"key":"10.1016\/j.niox.2024.04.009_bib44","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/1753-0407.12521","article-title":"Macro- and microvascular endothelial dysfunction in diabetes","volume":"9","author":"Shi","year":"2017","journal-title":"J. Diabetes"},{"key":"10.1016\/j.niox.2024.04.009_bib45","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.2337\/diabetes.48.12.2437","article-title":"Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide\/O2- imbalance in insulin-resistant rat aorta","volume":"48","author":"Shinozaki","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.niox.2024.04.009_bib22","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/hy1101.095331","article-title":"Supplementation with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats","volume":"38","author":"Hong","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.niox.2024.04.009_bib30","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/01.CIR.103.9.1282","article-title":"Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin","volume":"103","author":"Laursen","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2024.04.009_bib29","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1172\/JCI200314172","article-title":"Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension","volume":"111","author":"Landmesser","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.niox.2024.04.009_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/01.CIR.96.1.25","article-title":"High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells","volume":"96","author":"Cosentino","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2024.04.009_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/(SICI)1099-0895(1998090)14:3<241::AID-DMR216>3.0.CO;2-R","article-title":"Nitric oxide availability in diabetes mellitus","volume":"14","author":"Honing","year":"1997","journal-title":"Diabetes Metab. Rev."},{"key":"10.1016\/j.niox.2024.04.009_bib36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1006\/bbrc.1999.1422","article-title":"Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function","volume":"263","author":"Milstien","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.niox.2024.04.009_bib24","doi-asserted-by":"crossref","first-page":"H875","DOI":"10.1152\/ajpheart.00008.2003","article-title":"Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects","volume":"285","author":"Ihlemann","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.niox.2024.04.009_bib19","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s001250051551","article-title":"Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus","volume":"43","author":"Heitzer","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.niox.2024.04.009_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1172\/JCI119131","article-title":"Tetrahydrobiopterin restores endothelial function in hypercholesterolemia","volume":"99","author":"Stroes","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.niox.2024.04.009_bib21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0895-7061(01)02317-2","article-title":"Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals","volume":"15","author":"Higashi","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.niox.2024.04.009_bib18","doi-asserted-by":"crossref","first-page":"E36","DOI":"10.1161\/01.RES.86.2.e36","article-title":"Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for dysfunctional nitric oxide synthase","volume":"86","author":"Heitzer","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.niox.2024.04.009_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.niox.2024.04.009_bib48","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrd4608","article-title":"From sewer to savior \u2013 targeting the lymphatic system to promote drug exposure and activity","volume":"14","author":"Trevaskis","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.niox.2024.04.009_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3109\/10717544.2014.914986","article-title":"Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamics evaluation","volume":"23","author":"Dudhipala","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.niox.2024.04.009_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejpb.2016.10.022","article-title":"Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: pharmacokinetic and pharmacodynamics evaluation","volume":"110","author":"Dudhipala","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.niox.2024.04.009_bib32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ijpharm.2015.09.014","article-title":"Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: elucidation of mechanism of uptake using chylomicron flow blocking approach","volume":"495","author":"Makwana","year":"2015","journal-title":"Int. J. Pharm. (Amst.)"},{"key":"10.1016\/j.niox.2024.04.009_bib51","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.nano.2011.08.016","article-title":"Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanisms in rats","volume":"8","author":"Zhang","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.niox.2024.04.009_bib26","first-page":"2733","article-title":"Advanced drug delivery to the lymphatic system: lipid-based nanoformulations","volume":"8","author":"Khan","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.niox.2024.04.009_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ymgme.2003.10.002","article-title":"The fate of intravenously administered tetrahydrobiopterin and its implications for heterologous gene therapy of phenylketonuria","volume":"81","author":"Harding","year":"2004","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.niox.2024.04.009_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ymgme.2003.09.014","article-title":"Plasma tetrahydrobiopterin and its pharmacokinetics following oral administration","volume":"81","author":"Fiege","year":"2004","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.niox.2024.04.009_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.niox.2011.04.004","article-title":"Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease","volume":"25","author":"Crabtree","year":"2011","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2024.04.009_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3470001","article-title":"Tetrahydrobiopterin biosynthesis, regeneration and functions","volume":"347","author":"Thony","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.niox.2024.04.009_bib4","doi-asserted-by":"crossref","first-page":"9056","DOI":"10.1073\/pnas.0409594102","article-title":"Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase","volume":"102","author":"Chalupsky","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.niox.2024.04.009_bib41","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bcp.2014.05.010","article-title":"Cell type-specific recycling of tetrahydrobiopterin by dihydrofolate reductase explains differential effect of 7,8-dihydrobiopterin on endothelial nitric oxide synthase uncoupling","volume":"90","author":"Schmidt","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.niox.2024.04.009_bib50","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2013.04.035","article-title":"Human endothelial dihydrofolate reductase low activity limits vascular tetrahydrobiopterin recycling","volume":"63","author":"Whitsett","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.niox.2024.04.009_bib2","first-page":"1263","article-title":"Tetrahydrobiopterin attenuates superoxide-induced reduction in nitric oxide","volume":"3","author":"Bowers","year":"2011","journal-title":"Front. Biosci. (Online)"},{"key":"10.1016\/j.niox.2024.04.009_bib42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/abbi.1994.1140","article-title":"Inhibition of luminol-enhanced chemiluminescence by reduced pterins","volume":"310","author":"Shen","year":"1994","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.niox.2024.04.009_bib28","doi-asserted-by":"crossref","first-page":"22546","DOI":"10.1074\/jbc.M302227200","article-title":"Interactions of peroxynitrite, tetrahydriobioperin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase","volume":"278","author":"Kuzkaya","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2024.04.009_bib43","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.niox.2024.04.009_bib27","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/ATVBAHA.108.182584","article-title":"Therapeutic neovascularization by nanotechnology-medicated cell-selective delivery of pitavastatin into the vascular endothelium","volume":"29","author":"Kubo","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.niox.2024.04.009_bib38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jvs.2010.03.020","article-title":"Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit model of chronic hind limb ischemia","volume":"52","author":"Oda","year":"2010","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.niox.2024.04.009_bib37","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/ATVBAHA.115.307057","article-title":"Pioglitazone-incorporated nanoparticles prevent plaque destabilization and rupture by regulating monocyte\/macrophage differentiation in apoE-\/- mice","volume":"36","author":"Nakashiro","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860324000521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860324000521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T11:40:42Z","timestamp":1716378042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860324000521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":51,"alternative-id":["S1089860324000521"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2024.04.009","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticle-mediated delivery of tetrahydrobiopterin restores endothelial function in diabetic rats","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2024.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}